Literature DB >> 31741331

Hepatitis B Virus Infection: Overview.

Hong Li1, Libo Yan1, Ying Shi1, Duoduo Lv1, Jin Shang1, Lang Bai1, Hong Tang2.   

Abstract

Hepatitis B virus (HBV) is a DNA virus, belonging to the Hepadnaviridae family. It is a partially double-stranded DNA virus with a small viral genome (3.2 kb). Chronic HBV infection remains a global public health problem. If left untreated, chronic HBV infection can progress to end-stage liver disease, such as liver cirrhosis and hepatocellular carcinoma (HCC). In recent years, tremendous advances in the field of HBV basic and clinical research have been achieved, ranging from the HBV biological characteristics, immunopathogenesis, and animal models to the development of new therapeutic strategies and new drugs against HBV. In this overview, we begin with a brief history of HBV discovery and treatment milestones. We then briefly summarize the HBV research advances, which will be detailed in the following chapters.

Entities:  

Mesh:

Year:  2020        PMID: 31741331     DOI: 10.1007/978-981-13-9151-4_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

Review 1.  The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs.

Authors:  Jan Korbecki; Iwona Szatkowska; Patrycja Kupnicka; Wojciech Żwierełło; Katarzyna Barczak; Iwona Poziomkowska-Gęsicka; Jerzy Wójcik; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

2.  Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults.

Authors:  Juan Li; Fanyue Meng; Jingshan Zheng; Qi Liang; Huayu Li; Jingxin Li; Li Zhang; Jianhui Gan; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

3.  The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy.

Authors:  Weihua Cao; Minghui Li; Lu Zhang; Yao Lu; Shuling Wu; Ge Shen; Min Chang; Ruyu Liu; Yuanjiao Gao; Hongxiao Hao; Leiping Hu; Wei Yi; Calvin Q Pan; Yao Xie
Journal:  Biomed Res Int       Date:  2021-01-25       Impact factor: 3.411

4.  Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease.

Authors:  Bo Ye; Yifei Shen; Hui Chen; Sha Lin; Weilin Mao; Yuejiao Dong; Xuefen Li
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

5.  Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication <em>in vitro</em> by reinforcing miR-192-5p/ATG7-induced autophagy.

Authors:  Minkai Cao; Deping Yuan; Hongxiu Jiang; Guanlun Zhou; Chao Chen; Guorong Han
Journal:  Eur J Histochem       Date:  2022-09-02       Impact factor: 1.966

6.  Next Generation Sequencing-Based Identification of T-Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma.

Authors:  Yipeng Ma; Jiayu Ou; Tong Lin; Lei Chen; Junhui Chen; Mingjun Wang
Journal:  Hepatol Commun       Date:  2021-02-28

Review 7.  Emerging Hepatotropic Viruses in Cats: A Brief Review.

Authors:  Paolo Capozza; Nicola Decaro; Farzad Beikpour; Canio Buonavoglia; Vito Martella
Journal:  Viruses       Date:  2021-06-17       Impact factor: 5.048

Review 8.  The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma.

Authors:  Yanan Jiang; Xiuyun Shen; Moyondafoluwa Blessing Fasae; Fengnan Zhi; Lu Chai; Yue Ou; Hai Feng; Siwei Liu; Ying Liu; Shucai Yang
Journal:  Oxid Med Cell Longev       Date:  2021-10-16       Impact factor: 6.543

9.  Analysis of Serum MicroRNA-122 Expression at Different Stages of Chronic Hepatitis B Virus Infection.

Authors:  Wenjun Liu; Xinxiang He; Fei Huang
Journal:  Biomed Res Int       Date:  2021-06-03       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.